Olivier Brandicourt

Olivier Brandicourt

Director/Board Member at BENEVOLENTAI

Net worth: 352 640 $ as of 2024-02-28

69 year
Health Technology
Consumer Services
Health Services

Profile

Olivier Brandicourt is a French businessperson who has been at the head of 6 different companies is on the board of Alnylam Pharmaceuticals, Inc., National Committee on United States-China Relations, Inc. and Dewpoint Therapeutics, Inc. and Council Member at International Federation of Pharmaceutical Manufacturers and Vice President & Member at European Federation of Pharmaceutical Industries & Assns. Olivier Brandicourt previously occupied the position of Chief Executive Officer & Director at Sanofi and Chairman of Sanofi Biotechnology SAS (a subsidiary of Sanofi), President & General Manager-Emerging Markets at Pfizer Inc. Managing Director at Pfizer Ltd. Vice President of Warner-Lambert Co. Managing Director at Pfizer Manufacturing Ireland Unlimited Co. and Vice President & General Manager at Parke, Davis & Co. LLC (which are all subsidiaries of Pfizer Inc.), Executive Council Member at Bayer AG and Chairman-Management Board at Bayer HealthCare AG (a subsidiary of Bayer AG) and Chairman of Pharmaceutical Research & Manufacturers of America. Olivier Brandicourt received a doctorate and a graduate degree from Universite Paris Est Creteil Val De Marne and an undergraduate degree from Université de Paris 5 René Descartes.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2022-12-30 434,495 ( 0.30% ) 352 640 $ 2024-02-28
2023-05-17 0 ( -.--% ) - $ 2024-02-28

Olivier Brandicourt active positions

CompaniesPositionStart
ALNYLAM PHARMACEUTICALS, INC. Director/Board Member 2020-03-01
BENEVOLENTAI Director/Board Member 2022-04-21
BEIGENE, LTD. Director/Board Member 2024-01-21
Chairman -
Director/Board Member 2020-06-16
National Committee on United States-China Relations, Inc. Director/Board Member -
Corporate Officer/Principal -
All active positions of Olivier Brandicourt

Former positions of Olivier Brandicourt

CompaniesPositionEnd
Chairman 2019-08-31
SANOFI Chief Executive Officer 2019-08-30
░░░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
See the detail of Olivier Brandicourt's experience

Training of Olivier Brandicourt

Universite Paris Est Creteil Val De Marne Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Olivier Brandicourt's experience

Connections

99

1st degree connections

23

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
PFIZER, INC.

Health Technology

BAYER AG

Health Technology

SANOFI

Health Technology

ALNYLAM PHARMACEUTICALS, INC.

Health Technology

BEIGENE, LTD.

Health Technology

BENEVOLENTAI

Health Technology

Private companies16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Parke, Davis & Co. LLC

National Committee on United States-China Relations, Inc.

Health Services

Université de Paris 5 René Descartes

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Olivier Brandicourt